1 · The Virtual Lab
The Virtual Lab
Two services, available now: scientist-led analysis of your sequencing data, and independent verification of your target against public data. Both run on the same reproducible pipelines.
Aim I
Analysis platform & delivery
Independent QC gates the input
A laboratory that generated your data cannot credibly tell you it is bad. We did not generate it.
Provenance on every run
Input checksums, container digest, parameters, software versions, QC results, action log. Reproducible by a third party.
A scientist signs
Uncertainty stated, limits stated, a "what this does not show" section. Publication-grade, not publication-ready: the science stays yours.
Three ways to work with us
Available now
Scientist-led analysis
You send the data. Our scientists design, run, interpret and sign.
Available now
Sample-to-answer
You send samples. Sequencing through partner laboratories, QC, analysis, the finished study back.
In private development
Agentic AI, self-serve
The same pipelines and QC gates run by a scoped agent. Request access.
Specialist modules
- MRD analysis (research-grade) · Measurable-residual-disease analysis from NGS with an explicit limit of detection on every report. Research-grade; never a clinical result.
- Clonal evolution & phylogeny · Clonal architecture and how it changes under treatment, from bulk VAF or single-cell DNA.
- Clonal hematopoiesis (CH/CHIP) · CH calling, VAF trajectories and risk annotation from panels, WES or WGS, in any cohort where CH is a covariate or an endpoint.
- Same-patient multi-omic integration · Linking genotype, transcriptome and surface phenotype across modalities measured on the same individual.
Standard catalogue
Single-cell RNA-seq · Bulk RNA-seq · CITE-seq · WES / WGS · scATAC / multiome · Single-cell DNA · Spatial transcriptomics · Targeted panels · Methylation · Long-read · Immune repertoire · Multi-omic integration & biomarker modelling
Full catalogue with methodsAim II
Public Data Atlas & target verification
Available now
Target-Replication Reports
Does your target survive independent replication across public cohorts reprocessed through one uniform pipeline? We report the answer either way.
In development
Public Data Atlas
Public disease data reprocessed through the same pipelines as every client run, negatives kept. Grows from every report.
Research use only. Not for use in diagnostic procedures. BioMedsAI is not a CLIA-certified laboratory and does not perform clinical testing. BioMedsAI is not a notified body and holds no accreditation for conformity assessment. Evaluations are independent scientific opinions, not regulatory determinations. Sequencing is performed by qualified partner laboratories under their own accreditations.
Schedule a scoping meeting.
Thirty minutes with a scientist on your data and your question. No data moves before a written, signed scope.